Co-Diagnostics, Offering Friday, July 31, 2026 0.00 Neutral

Co-Diagnostics agrees to sell common stock via Maxim Group as placement agent

Co-Diagnostics Inc. has entered into a placement agency agreement with Maxim Group LLC. Under this agreement, Maxim will act as the exclusive placement agent to sell Common Stock, Pre-Funded Warrants, and Common Warrants directly to investors as induced exercises of existing warrants. The transaction is conditional on market conditions.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day